<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31341250</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The activation of Mucolipin TRP channel 1 (TRPML1) protects motor neurons from L-BMAA neurotoxicity by promoting autophagic clearance.</ArticleTitle><Pagination><StartPage>10743</StartPage><MedlinePgn>10743</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10743</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-46708-5</ELocationID><Abstract><AbstractText>Cellular clearance mechanisms including the autophagy-lysosome pathway are impaired in amyotrophic lateral sclerosis (ALS). One of the most important proteins involved in the regulation of autophagy is the lysosomal Ca<sup>2+</sup> channel Mucolipin TRP channel 1 (TRPML1). Therefore, we investigated the role of TRPML1 in a neuronal model of ALS/Parkinson-dementia complex reproduced by the exposure of motor neurons to the cyanobacterial neurotoxin beta-methylamino-L-alanine (L-BMAA). Under these conditions, L-BMAA induces a dysfunction of the endoplasmic reticulum (ER) leading to ER stress and cell death. Therefore we hypothesized a dysfunctional coupling between lysosomes and ER in L-BMAA-treated motor neurons. Here, we showed that in motor neuronal cells TRPML1 as well as the lysosomal protein LAMP1 co-localized with ER. In addition, TRPML1 co-immunoprecipitated with the ER Ca<sup>2+</sup> sensor STIM1. Functionally, the TRPML1 agonist ML-SA1 induced lysosomal Ca<sup>2+</sup> release in a dose-dependent way in motor neuronal cells. The SERCA inhibitor thapsigargin increased the fluorescent signal associated with lysosomal Ca<sup>2+</sup> efflux in the cells transfected with the genetically encoded Ca<sup>2+</sup> indicator GCaMP3-ML1, thus suggesting an interplay between the two organelles. Moreover, chronic exposure to L-BMAA reduced TRPML1 protein expression and produced an impairment of both lysosomal and ER Ca<sup>2+</sup> homeostasis in primary motor neurons. Interestingly, the preincubation of ML-SA1, by an early activation of AMPK and beclin 1, rescued motor neurons from L-BMAA-induced cell death and reduced the expression of the ER stress marker GRP78. Finally, ML-SA1 reduced the accumulation of the autophagy-related proteins p62/SQSTM1 and LC3-II in L-BMAA-treated motor neurons. Collectively, we propose that the pharmacological stimulation of TRPML1 can rescue motor neurons from L-BMAA-induced toxicity by boosting autophagy and reducing ER stress.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tedeschi</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Division of Pharmacology, Department of Neuroscience, Reproductive and Odontostomatological Sciences, School of Medicine, "Federico II" University of Naples, Via S.Pansini 5, Napoli, 80131, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrozziello</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Pharmacology, Department of Neuroscience, Reproductive and Odontostomatological Sciences, School of Medicine, "Federico II" University of Naples, Via S.Pansini 5, Napoli, 80131, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sisalli</LastName><ForeName>Maria Jos&#xe9;</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Pharmacology, Department of Neuroscience, Reproductive and Odontostomatological Sciences, School of Medicine, "Federico II" University of Naples, Via S.Pansini 5, Napoli, 80131, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boscia</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Pharmacology, Department of Neuroscience, Reproductive and Odontostomatological Sciences, School of Medicine, "Federico II" University of Naples, Via S.Pansini 5, Napoli, 80131, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canzoniero</LastName><ForeName>Lorella Maria Teresa</ForeName><Initials>LMT</Initials><AffiliationInfo><Affiliation>Division of Pharmacology, Department of Science and Technology-DST, University of Sannio, via Port'Arsa 11, 82100, Benevento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Secondo</LastName><ForeName>Agnese</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pharmacology, Department of Neuroscience, Reproductive and Odontostomatological Sciences, School of Medicine, "Federico II" University of Naples, Via S.Pansini 5, Napoli, 80131, Italy. secondo@unina.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000599">Amino Acids, Diamino</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000087522">Cyanobacteria Toxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000091342">Endoplasmic Reticulum Chaperone BiP</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000717248">Hspa5 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599935">ML-SA1 compound</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657466">Mcoln1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010797">Phthalimides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011804">Quinolines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050051">Transient Receptor Potential Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>108SA6URTV</RegistryNumber><NameOfSubstance UI="C001824">beta-N-methylamino-L-alanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>SY7Q814VUP</RegistryNumber><NameOfSubstance UI="D002118">Calcium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000599" MajorTopicYN="N">Amino Acids, Diamino</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002118" MajorTopicYN="N">Calcium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000087522" MajorTopicYN="N">Cyanobacteria Toxins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004721" MajorTopicYN="N">Endoplasmic Reticulum</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091342" MajorTopicYN="N">Endoplasmic Reticulum Chaperone BiP</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006822" MajorTopicYN="N">Hybrid Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008247" MajorTopicYN="N">Lysosomes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010797" MajorTopicYN="N">Phthalimides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011804" MajorTopicYN="N">Quinolines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050051" MajorTopicYN="N">Transient Receptor Potential Channels</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31341250</ArticleId><ArticleId IdType="pmc">PMC6656764</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-46708-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-46708-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chou, S. M. Pathology-light microscopy of amyotrophic lateral sclerosis in Handbook of Amyotrophic Lateral Sclerosis (ed. Smith, R. A.) 133&#x2013;181 (Marcel Deckker Inc., 1992).</Citation></Reference><Reference><Citation>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno MS, Bosco DA. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front. Cell. Neurosci. 2013;7:253. doi: 10.3389/fncel.2013.00253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00253</ArticleId><ArticleId IdType="pmc">PMC3863749</ArticleId><ArticleId IdType="pubmed">24379756</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2011;68:1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G, Shimogori T, Hattori N, Nukina N. TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum. Mol. Genet. 2015;24:4429&#x2013;4442. doi: 10.1093/hmg/ddv179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv179</ArticleId><ArticleId IdType="pubmed">25972374</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura AL, et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004;75:822&#x2013;831. doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadano S, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 2001;29:166&#x2013;173. doi: 10.1038/ng1001-166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1001-166</ArticleId><ArticleId IdType="pubmed">11586298</ArticleId></ArticleIdList></Reference><Reference><Citation>Skibinski G, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 2005;37:806&#x2013;808. doi: 10.1038/ng1609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1609</ArticleId><ArticleId IdType="pubmed">16041373</ArticleId></ArticleIdList></Reference><Reference><Citation>Puls I, et al. Mutant dynactin in motor neuron disease. Nat. Genet. 2003;33:455&#x2013;456. doi: 10.1038/ng1123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1123</ArticleId><ArticleId IdType="pubmed">12627231</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CH, et al. Mutations in the profilin1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488:499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow CY, et al. Deleterious variants of Fig. 4, a phosphoinositide phosphatase, in patients with ALS. Am. J. Hum. Genet. 2009;84:85&#x2013;88. doi: 10.1016/j.ajhg.2008.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.12.010</ArticleId><ArticleId IdType="pmc">PMC2668033</ArticleId><ArticleId IdType="pubmed">19118816</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chomosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuire, V. &amp; Nelson, L. M. Epidemiology of ALS in: Amyotrophic Lateral Sclerosis (eds Mitsumoto, H., Przedborski, S. &amp; Gordon, P. H.) 17&#x2013;41 (Taylor &amp; Francis, 2006).</Citation></Reference><Reference><Citation>Murch SJ, Cox PA, Banack SA, Steele JC, Sacks OW. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol. Scand. 2004;110:267&#x2013;269. doi: 10.1111/j.1600-0404.2004.00320.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2004.00320.x</ArticleId><ArticleId IdType="pubmed">15355492</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis AM, Groen EJN, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125:777&#x2013;794. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens BM, Miller N, Ma YC. Impaired Autophagy and Defective Mitochondrial Function: Converging Paths on the Road to Motor Neuron Degeneration. Front. Cell Neurosci. 2016;10:44. doi: 10.3389/fncel.2016.00044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00044</ArticleId><ArticleId IdType="pmc">PMC4776126</ArticleId><ArticleId IdType="pubmed">26973461</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I, et al. SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol. 2013;70:1403&#x2013;1410. doi: 10.1001/jamaneurol.2013.3849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.3849</ArticleId><ArticleId IdType="pmc">PMC4199096</ArticleId><ArticleId IdType="pubmed">24042580</ArticleId></ArticleIdList></Reference><Reference><Citation>King A, et al. Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Th MAPT (tau) variant. Acta Neuropathol. 2013;125:303&#x2013;310. doi: 10.1007/s00401-012-1050-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1050-0</ArticleId><ArticleId IdType="pubmed">23053136</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura A, et al. Dysregulation of the proteasome increases the toxicity of ALS-linked mutant SOD1. Genes Cells. 2014;19:209&#x2013;224. doi: 10.1111/gtc.12125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12125</ArticleId><ArticleId IdType="pmc">PMC4207061</ArticleId><ArticleId IdType="pubmed">24450587</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidal RL, Matus S, Bargsted L, Hetz C. Targeting autophagy in neurodegenerative diseases. Trends Pharmacol. Sci. 2014;35:583&#x2013;591. doi: 10.1016/j.tips.2014.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2014.09.002</ArticleId><ArticleId IdType="pubmed">25270767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Yang B, Mo X, Xiao H. Mechanism and Regulation of Autophagy and Its Role in Neuronal Diseases. Mol Neurobiol. 2015;52:1190&#x2013;1209. doi: 10.1007/s12035-014-8921-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8921-4</ArticleId><ArticleId IdType="pubmed">25316381</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IF, et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl. Acad. Sci. USA. 2012;109:15024&#x2013;15029. doi: 10.1073/pnas.1206362109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1206362109</ArticleId><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat. Chem. Biol. 2014;10:677&#x2013;685. doi: 10.1038/nchembio.1563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1563</ArticleId><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JK, Shin JH, Lee JE, Choi EJ. Role of autophagy in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta. 2015;1852:2517&#x2013;&#x2013;2524. doi: 10.1016/j.bbadis.2015.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.08.005</ArticleId><ArticleId IdType="pubmed">26264610</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo K, et al. Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy. 2013;9:1308&#x2013;1320. doi: 10.4161/auto.25188.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.25188</ArticleId><ArticleId IdType="pubmed">23851366</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong XP, et al. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature. 2008;455:992&#x2013;996. doi: 10.1038/nature07311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07311</ArticleId><ArticleId IdType="pmc">PMC4301259</ArticleId><ArticleId IdType="pubmed">18794901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CO, Li R, Montell C, Venkatachalam K. Drosophila TRPML is required for TORC1 activation. Curr. Biol. 2012;22:1616&#x2013;1621. doi: 10.1016/j.cub.2012.06.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2012.06.055</ArticleId><ArticleId IdType="pmc">PMC3443270</ArticleId><ArticleId IdType="pubmed">22863314</ArticleId></ArticleIdList></Reference><Reference><Citation>Bargal R, et al. Identification of the gene causing mucolipidosis type IV. Nat. Genet. 2000;26:118&#x2013;123. doi: 10.1038/79095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/79095</ArticleId><ArticleId IdType="pubmed">10973263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, et al. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum. Mol. Genet. 2000;9:2471&#x2013;2478. doi: 10.1093/hmg/9.17.2471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/9.17.2471</ArticleId><ArticleId IdType="pubmed">11030752</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassi MT, et al. Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV. Am. J. Hum. Genet. 2000;67:1110&#x2013;1120. doi: 10.1016/S0002-9297(07)62941-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9297(07)62941-3</ArticleId><ArticleId IdType="pmc">PMC1288553</ArticleId><ArticleId IdType="pubmed">11013137</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. MCOLN1 is a ROS sensor in lysosomes that regulates autophagy. Nat. Commun. 2016;7:12109. doi: 10.1038/ncomms12109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12109</ArticleId><ArticleId IdType="pmc">PMC4931332</ArticleId><ArticleId IdType="pubmed">27357649</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Q, Yang Y, Zhong XZ, Dong XP. The lysosomal Ca2+ release channel TRPML1 regulates lysosome size by activating calmodulin. J. Biol. Chem. 2017;292:8424&#x2013;8435. doi: 10.1074/jbc.M116.772160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.772160</ArticleId><ArticleId IdType="pmc">PMC5437247</ArticleId><ArticleId IdType="pubmed">28360104</ArticleId></ArticleIdList></Reference><Reference><Citation>Medinas DB, et al. Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2018;115:8209&#x2013;8214. doi: 10.1073/pnas.1801109115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1801109115</ArticleId><ArticleId IdType="pmc">PMC6094144</ArticleId><ArticleId IdType="pubmed">30038021</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrozziello T, et al. ApoSOD1 lacking dismutase activity neuroprotects motor neurons exposed to beta-methylamino-L-alanine though the 2+ /Akt/ERK1/2 prosurvival pathway. Cell Death Differ. 2017;24:511&#x2013;522. doi: 10.1038/cdd.2016.154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2016.154</ArticleId><ArticleId IdType="pmc">PMC5344211</ArticleId><ArticleId IdType="pubmed">28085149</ArticleId></ArticleIdList></Reference><Reference><Citation>Penny CJ, Kilpatrick BS, Eden ER, Patel S. Coupling acidic organelles with the ER though Ca2+ microdomains at membrane contact sites. Cell Calcium. 2015;58:387&#x2013;396. doi: 10.1016/j.ceca.2015.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2015.03.006</ArticleId><ArticleId IdType="pubmed">25866010</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen D, et al. Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release. Nat. Commun. 2012;3:731. doi: 10.1038/ncomms1735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1735</ArticleId><ArticleId IdType="pmc">PMC3347486</ArticleId><ArticleId IdType="pubmed">22415822</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrity AG, et al. The endoplasmic reticulum, not the pH gradient, drives calcium refilling of lysosomes. Elife. 2016;5:e15887. doi: 10.7554/eLife.15887.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.15887</ArticleId><ArticleId IdType="pmc">PMC4909396</ArticleId><ArticleId IdType="pubmed">27213518</ArticleId></ArticleIdList></Reference><Reference><Citation>Curcio-Morelli C, et al. Macroautophagy is defective in mucolipin-1-deficient mouse neurons. Neurobiol. Dis. 2010;40:370&#x2013;377. doi: 10.1016/j.nbd.2010.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2010.06.010</ArticleId><ArticleId IdType="pmc">PMC4392647</ArticleId><ArticleId IdType="pubmed">20600908</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina DL, Ballabio A. Lysosomal calcium regulates autophagy. Autophagy. 2015;11:970&#x2013;971. doi: 10.1080/15548627.2015.1047130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1047130</ArticleId><ArticleId IdType="pmc">PMC4502748</ArticleId><ArticleId IdType="pubmed">26000950</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid HO, Yadav RK, Kim HR, Chae HJ. ER stress: Autophagy induction, inhibition and selection. Autophagy. 2015;11:1956&#x2013;1977. doi: 10.1080/15548627.2015.1091141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1091141</ArticleId><ArticleId IdType="pmc">PMC4824587</ArticleId><ArticleId IdType="pubmed">26389781</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirabella R, et al. Anoxia-induced NF-kappaB-dependent upregulation of NCX1 contributes to Ca2+ refilling into endoplasmic reticulum in cortical neurons. Stroke. 2009;40:922&#x2013;929. doi: 10.1161/STROKEAHA.108.531962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.108.531962</ArticleId><ArticleId IdType="pubmed">19164785</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H, et al. Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis. J. Neurosci. 2014;34:2331&#x2013;2348. doi: 10.1523/JNEUROSCI.2689-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2689-13.2014</ArticleId><ArticleId IdType="pmc">PMC3913875</ArticleId><ArticleId IdType="pubmed">24501372</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen Dao K.H., Thombre Ravi, Wang Jiou. Autophagy as a common pathway in amyotrophic lateral sclerosis. Neuroscience Letters. 2019;697:34&#x2013;48. doi: 10.1016/j.neulet.2018.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.04.006</ArticleId><ArticleId IdType="pmc">PMC6170747</ArticleId><ArticleId IdType="pubmed">29626651</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Ghasemi M, Brown RH., Jr. Emerging mechanisms of molecular pathology in ALS. J. Clin. Invest. 2015;125:2548. doi: 10.1172/JCI82693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI82693</ArticleId><ArticleId IdType="pmc">PMC4518693</ArticleId><ArticleId IdType="pubmed">26030230</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 2010;13:1396&#x2013;1403. doi: 10.1038/nn.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibenhener ML, et al. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol. Cell. Biol. 2004;24:8055&#x2013;8068. doi: 10.1128/MCB.24.18.8055-8068.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.18.8055-8068.2004</ArticleId><ArticleId IdType="pmc">PMC515032</ArticleId><ArticleId IdType="pubmed">15340068</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsui S, et al. Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1H46R-expressing ALS mouse model. Mol. Brain. 2018;11:30. doi: 10.1186/s13041-018-0373-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-018-0373-8</ArticleId><ArticleId IdType="pmc">PMC5975400</ArticleId><ArticleId IdType="pubmed">29843805</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, et al. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 2009;23:2294&#x2013;2306. doi: 10.1101/gad.1830709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1830709</ArticleId><ArticleId IdType="pmc">PMC2758741</ArticleId><ArticleId IdType="pubmed">19762508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18:571&#x2013;580. doi: 10.1038/cdd.2010.191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2010.191</ArticleId><ArticleId IdType="pmc">PMC3131912</ArticleId><ArticleId IdType="pubmed">21311563</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto N, et al. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 2007;1167:112&#x2013;117. doi: 10.1016/j.brainres.2007.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2007.06.045</ArticleId><ArticleId IdType="pubmed">17689501</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming A, Noda T, Yoshimori T, Rubinsztein DC. Chemical modulators of autophagy as biological probes and potential therapeutics. Nat. Chem. Biol. 2011;7:9&#x2013;17. doi: 10.1038/nchembio.500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.500</ArticleId><ArticleId IdType="pubmed">21164513</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441:885&#x2013;889. doi: 10.1038/nature04724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04724</ArticleId><ArticleId IdType="pubmed">16625204</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang QJ, et al. Induction of autophagy in axonal dystrophy and degeneration. J. Neurosci. 2006;26:8057&#x2013;8068. doi: 10.1523/JNEUROSCI.2261-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2261-06.2006</ArticleId><ArticleId IdType="pmc">PMC6673783</ArticleId><ArticleId IdType="pubmed">16885219</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick ND, et al. Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS. Proc. Natl. Acad. Sci. USA. 2017;114:E8294&#x2013;E8303. doi: 10.1073/pnas.1704294114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704294114</ArticleId><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman N, et al. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992;194:209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Graber DJ, Harris BT. Purification and culture of spinal motor neurons from rat embryos. Cold Spring Harb. Protoc. 2013;2013:319&#x2013;326. doi: 10.1101/pdb.prot074161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/pdb.prot074161</ArticleId><ArticleId IdType="pubmed">23547162</ArticleId></ArticleIdList></Reference><Reference><Citation>Scorziello A, et al. NCX3 regulates mitochondrial Ca(2+) handling though the AKAP121-anchored signaling complex and prevents hypoxia-induced neuronal death. J. Cell. Sci. 2013;126:5566&#x2013;5577. doi: 10.1242/jcs.129668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.129668</ArticleId><ArticleId IdType="pubmed">24101730</ArticleId></ArticleIdList></Reference><Reference><Citation>Secondo A, et al. Na+/Ca2+ exchanger 1 on nuclear envelope controls PTEN/Akt pathway via nucleoplasmic Ca2+ regulation during neuronal differentiation. Cell Death Discov. 2018;4:12. doi: 10.1038/s41420-017-0018-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-017-0018-1</ArticleId><ArticleId IdType="pmc">PMC5841316</ArticleId><ArticleId IdType="pubmed">29531809</ArticleId></ArticleIdList></Reference><Reference><Citation>Secondo A, et al. BHK cells transfected with NCX3 are more resistant to hypoxia followed by reoxygenation than those transfected with NCX1 and NCX2: possible relationship with mitochondrial membrane potential. Cell Calcium. 2007;42:521&#x2013;535. doi: 10.1016/j.ceca.2007.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2007.01.006</ArticleId><ArticleId IdType="pubmed">17343909</ArticleId></ArticleIdList></Reference><Reference><Citation>Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985;260:3440&#x2013;3450.</Citation><ArticleIdList><ArticleId IdType="pubmed">3838314</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbanczyk J, Chernysh O, Condrescu M, Reeves JP. Sodium-calcium exchange does not require allosteric calcium activation at high cytosolic sodium concentrations. J. Physiol. 2006;575:693&#x2013;705. doi: 10.1113/jphysiol.2006.113910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2006.113910</ArticleId><ArticleId IdType="pmc">PMC1995697</ArticleId><ArticleId IdType="pubmed">16809364</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Ann. Biochem. 1976;72:248&#x2013;254. doi: 10.1016/0003-2697(76)90527-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(76)90527-3</ArticleId><ArticleId IdType="pubmed">942051</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>